[1]Patent:WO2013/86266,2013,A2.Locationinpatent:Paragraph000112
[1]Mason,JeremyD.;Myers,AndrewG.;Pote,AdityaR.;Terwilliger,DanielW.[JournaloftheAmericanChemicalSociety,2021,vol.143,#29,p.11019-11025]
14810-93-6
26944-48-9 | Glibornuride | AA00C2KB | MFCD00869202
2958-04-5 | taurohyodeoxycholic acid | AA00C2QF | MFCD00907891
201789-32-4 | D-Glucopyranuronic acid, methyl ester, tetrabenzoate | AA00C2WL | MFCD11113472
20168-88-1 | 6-demethylgriseofulvin | AA00C336 | MFCD28898511
29606-06-2 | TriMethopriM IMpurity C | AA00C3A5 | MFCD21363892
220341-09-3 | PHENYLPROPYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE | AA00C3LZ | MFCD08703883
21313-49-5 | Pht-gly-onp | AA00C3ZM | MFCD00190995
24102-11-2 | 2-n-propyl-4-pentynoic acid | AA00C4FN | MFCD07780275
207305-60-0 | Butanoic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (2S)- (9CI) | AA00C53E | MFCD18835699
35468-44-1 | BROMOCYCLOPENTANE-D9 | AA00C5D0 | MFCD00190386